|
|
| MRD / Regn No. |
: 20260000602 |
Date |
: 01/07/2026 |
| Patient Name |
: Saraswathi Annadurai |
Age & Gender |
: 45 Yrs. / Female |
| Contact No. |
: 578883339 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (01/Jul/2024) | OBESITY (01/Jul/2021) | |
|
Subjective |
: |
DM FOR 2 YEARS |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,OBESITY,HX OF NEPHROLITHIASIS,VITAMIN D DEFICEINCY,INCREASE FIB4 SCORE |
|
Plan |
: |
ADD GLP1RA SGLT2I,ADD VITAMIN D,SEE ME IN 1 MONTH,GET FIBROSCAN AND REVIEW WITH RESULTS |
|
| Salient Investigations |
: |
HEMOGLOBIN: 13.1 g/dL | MCH: 27 pg | MCHC: 33 gm % | MCV: 82 fl | PCV: 40 % | PLATELETS: 381 thou cells/ ul | RBC COUNT: 4.82 million/ul | TOTAL COUNT WBC: 9.89 Cells/cmm | FREE T4 : 1.16 ng/dL | TSH : 0.940 mIU/L | VITAMIN D (25 OH): 22.2 ng/mL | NT PROBNP : 27 pg/mL | FASTING PLASMA GLUCOSE (FPG): 161 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 8.6 % | POST PRANDIAL GLUCOSE (2HPP): 304 mg/dL | CREATININE: 0.54 mg/dL | HIGH SENSITIVE C REACTIVE PROTEIN: 8.27 mg/L | BUN BLOOD UREA NITROGEN: 9.0 mg/dL | UREA: 19 mg/dL | A\G RATIO: 1.61 g/dl | ALBUMIN (SERUM): 4.76 g/dL | ALKALINE PHOSPHOTASE: 95 IU/L | DIRECT BILIRUBIN: 0.22 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 43 U/L | GLOBULIN: 2.96 g/dl | INDIRECT BILIRUBIN: 0.37 | SGOT (AST): 39 U/L | SGPT (ALT): 49 IU/L | TOTAL BILIRUBIN: 0.59 mg/dL | TOTAL PROTEIN: 7.72 g/dl | HDL HIGH DENSITY LIPOPROTEIN: 35 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 102 mg/dL | TGL TRIGLYCERIDE: 250 mg/dL | TOTAL CHO/HDL RATIO: 4.5 | TOTAL CHOLESTEROL: 161 mg/dl | VLDL: 50 mg/dl | MICROALBUMIN CREATININE RATIO: 25.40 mcg/mg | EGFR EGLOMERULAR FILTRATION RATE: 130.73 mL/min/1.73m2 | FIB4: 0.66 | EGFR EGLOMERULAR FILTRATION RATE: 130.73 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 130.73 mL/min/1.73m2 | FIB4: 0.66 | FIB4: 0.66 | CUP DISC RATIO L: 0.45 | CUP DISK RATIO R: 0.63 | ABI LEFT: 0.95 | ABI RIGHT: 0.98 | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION SEMAGLUTIDE
SEMATRINITY 0.25
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA VOMITING OR VISUAL DISTURBANCES | |
|
2 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
3 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
4 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: AVOID CONJEE SWEETS CHOCOLATES AND SIMPLE SUGARS OF ANY KIND,AVOID OR REDUCE RESTAURANT FOOD,AVOID PROCESSED FOOD,EXERCISE 150 MINUTES PER WEEK,REDUCE CARBOHYDRATE BY 20%,REDUCE SEDENTARY TIME |
| Next Visit |
: 31/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
|
